Research and Clinical Trials
Dr. Sloan W. Rush is actively involved in research as the principal investigator in multiple clinical trials. Having been involved in over 40 research projects by age 40, he has presented dozens of journal publications at the most prestigious scientific meetings across the country. Dr. Sloan is a clinical professor locally at Texas Tech University Health Sciences Center where he is able to collaborate with academic researchers and also participate in the training of medical students pursuing ophthalmology.
By the development of prospective clinical trials, we are able to provide novel and cutting-edge treatment options for patients here in our region while also helping refine new technology for the benefit of all By the development of prospective clinical trials, we are able to provide novel and cutting-edge treatment options for patients here in our region while also helping refine new technology for the benefit of all people worldwide. Dr. Sloan is the first ophthalmologist to use topical corneal stem cell therapy-derived products for treatment of dry eye disease in human clinical trials. He has over a dozen active and NIH-registered research projects currently in progress, right here in Amarillo, Texas. Below is a sampling of some of the active studies:
Corneal epithelial stem cells and dry eye disease. National Clinical Trials ID Number: NCT03302273
Topography-guided and accelerated corneal collagen cross-linking. National Clinical Trials ID Number: NCT04378764.
Same-day bilateral cataract surgery. National Clinical Trials ID Number: NCT01841957
The effects of corneal collagen cross-linking. National Clinical Trials ID Number: NCT01708538
NIH STTR FastTrack Phase 1 and Phase 2 award granted investigating the use of human cultured endothelial stem cells for corneal regeneration and wound healing in an animal model.